Fenchel G, Storf R, Hoffmeister H E, Heller W
Basic Res Cardiol. 1986;81 Suppl 1:117-25. doi: 10.1007/978-3-662-11374-5_12.
Using an isolated rat heart preparation (Langendorff perfusion, perfusion pressure 100 cm H2O) the response of the hypertrophied heart (spontaneous hypertensive rats lv/bw ratio 3.6 +/- 0.5) to global normothermic (30 min) and hypothermic (25 degrees C, 120 min) ischemic and cardioplegic arrest and reperfusion (30 min) was examined and compared with normal hearts (Wistar rats lv/bw ratio 2.0 +/- 0.3). St. Thomas solution and verapamil (2 mg/l Ringer solution) were used as cardioplegic agents. Before ischemia hypertrophied hearts had a significantly higher pressure-rate product, a lower myocardial perfusion/g myocardium and a lower myocardial ATP and adenine nucleotide content. Unmodified ischemia reduced myocardial function in the hypertrophied hearts to a greater degree than in normal hearts in both normo- and hypothermia. St. Thomas solution and verapamil protected significantly the myocardial function in the normal and hypertrophied heart after normothermic ischemia in a similar manner (60-70% of the initial value). In the hypertrophied ventricle ATP decay and adenine nucleotide loss was greater in verapamil than in St. Thomas solution treated hearts. In hypothermic ischemia only St. Thomas solution protected left ventricular function and adenine nucleotide loss in both normal and hypertrophied hearts. Verapamil was ineffective in the normal ventricle and protected left ventricular function but not the ATP and adenine nucleotide decay in the hypertrophied heart.
采用离体大鼠心脏制备方法(Langendorff灌注,灌注压力100 cm H₂O),研究了肥厚心脏(自发性高血压大鼠左心室/体重比值3.6±0.5)对整体常温(30分钟)和低温(25℃,120分钟)缺血、心脏停搏及再灌注(30分钟)的反应,并与正常心脏(Wistar大鼠左心室/体重比值2.0±0.3)进行比较。使用圣托马斯溶液和维拉帕米(2 mg/l林格溶液)作为心脏停搏剂。缺血前,肥厚心脏的压力-心率乘积显著更高,心肌灌注/每克心肌更低,心肌ATP和腺嘌呤核苷酸含量更低。在常温和低温条件下,未改良的缺血对肥厚心脏心肌功能的降低程度均大于正常心脏。圣托马斯溶液和维拉帕米以相似方式显著保护了常温缺血后正常和肥厚心脏的心肌功能(达到初始值的60 - 70%)。在肥厚心室中,维拉帕米处理组的ATP衰减和腺嘌呤核苷酸损失比圣托马斯溶液处理组更大。在低温缺血时,只有圣托马斯溶液保护了正常和肥厚心脏的左心室功能及腺嘌呤核苷酸损失。维拉帕米对正常心室无效,在肥厚心脏中可保护左心室功能,但不能保护ATP和腺嘌呤核苷酸的衰减。